Translational Cancer Research Impact Factor, Indexing, Ranking

Translational Cancer Research (TCR) is a scholarly journal dedicated to publishing research in the field of Medicine. AME Publishing Company is the publisher of this esteemed journal. The P-ISSN assigned to Translational Cancer Research is 2218-676X and its abbreviated form is Transl Cancer Res.

Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; https://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in PubMed/PubMed Central and Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer, results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards.

Translational Cancer Research Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Translational Cancer Research Journal is Transl Cancer Res.

The Ranking of Translational Cancer Research in 2026 is 17002. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.

The Impact Factor of Translational Cancer Research in 2026 is 0.9. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors

The SCImago of Translational Cancer Research in 2026 is 0.247. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.

The H-Index of Translational Cancer Research in 2026 is 36. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.

The Quartile of Translational Cancer Research is Q3. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.

The Translational Cancer Research is indexed in (Indexing details)

• 1. Web of Science
• 2. UGC
• 3. Scopus
• 4. Google Scholar

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.

The Editor-in-chief of Translational Cancer Research is Eric Y Chuang, ScD, EMBA

Translational Cancer Research Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of Translational Cancer Research is 1390 USD

Translational Cancer Research Call for paper : Translational Cancer Research invites original research contributions for consideration of publication in Translational Cancer Research journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.

Publishing in Translational Cancer Research involves the following steps:

• Research: Conduct high-quality, impactful research in the field of Medicine.
• Familiarize Yourself: Read and understand the aims and scope of Translational Cancer Research to ensure your work aligns with their focus.
• Manuscript Preparation: Prepare your manuscript according to the Translational Cancer Research guidelines, including formatting, length, and referencing style.
• Submission: Submit your manuscript through the journal's online submission system.

• Journal Website
• PubMed
• Scopus
• SCImago